Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response

Immunology

Volumn 121, Issue 2, 2007, Pages 174-182

  Wang, Jingxue ^a   Zhang, Yongmin ^b   Wei, Jing ^a   Zhang, Xiaoping ^a   Zhang, Bei ^a   Zhu, Zhenyuan ^b,c   Zou, Wei ^a   Wang, Yiqin ^a   Mou, Zhirong ^a   Ni, Bin ^a   Wu, Yuzhang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b ECOLE NORMALE SUPÉRIEURE   (France)

^c TIANJIN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

DC SIGN; Dendritic cells; Lewis X; T cells; Vaccination

Indexed keywords

ANTIBODY; BIOTIN; BIOTIN STREPTAVIDIN OVALBUMIN CONJUGATE; CD209 ANTIGEN; CD40 LIGAND; CHROMIUM 51; GAMMA INTERFERON; INTERLEUKIN 10; LEWIS X OLIGOSACCHARIDE OVALBUMIN CONJUGATE; LIGAND; LIPOPOLYSACCHARIDE; OVALBUMIN; PLASMID VECTOR; STREPTAVIDIN; UNCLASSIFIED DRUG; VACCINE;

ANTIGEN SPECIFICITY; ARTICLE; BIOASSAY; CD8+ T LYMPHOCYTE; CELL COUNT; CELL MATURATION; CELLULAR IMMUNITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG SYNTHESIS; DRUG TARGETING; ENZYME LINKED IMMUNOSPOT ASSAY; EXPRESSION VECTOR; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOREGULATION; INTRACELLULAR SPACE; MEDIATOR; MOLECULAR MIMICRY; PRIORITY JOURNAL; STAINING; T LYMPHOCYTE;

ANTIGENS; CD8-POSITIVE T-LYMPHOCYTES; CELL ADHESION MOLECULES; CELL DIFFERENTIATION; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES, T-LYMPHOCYTE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; OLIGOSACCHARIDES; OVALBUMIN; RECEPTORS, CELL SURFACE;

EID: 34247515189     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2007.02554.x     Document Type: Article

References (35)

1. Bonifaz L, Bonnyay D, Mahnke K, Rivera M, Nussenzweig MC, Steinman RM. Efficient targeting of protein antigen to the dendritic cell receptor DEC-205 in the steady state leads to antigen presentation on major histocompatibility complex class I products and peripheral CD8+ T cell tolerance. J Exp Med 2002 196 : 1627 38.
2. Ramakrishna V, Treml JF, Vitale L, Connolly JE et al. Mannose receptor targeting of tumor antigen pmel17 to human dendritic cells directs anti-melanoma T cell responses via multiple HLA molecules. J Immunol 2004 172 : 2845 52.
3. Geijtenbeek TB, Kwon DS, Torensma R et al. DC-SIGN, a dendritic cell-specific HIV-1-binding protein that enhances trans-infection of T cells. Cell 2000 100 : 587 97.
4. Soilleux EJ, Morris LS, Leslie G et al. Constitutive and induced expression of DC-SIGN on dendritic cell and macrophage subpopulations in situ and in vitro. J Leukoc Biol 2002 71 : 445 57.
5. Engering A, Geijtenbeek TB, van Vliet SJ et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002 168 : 2118 26.
6. Moris A, Nobile C, Buseyne F, Porrot F, Abastado JP, Schwartz O. DC-SIGN promotes exogenous MHC-I-restricted HIV-1 antigen presentation. Blood 2004 103 : 2648 54.
7. Halary F, Amara A, Lortat-Jacob H et al. Human cytomegalovirus binding to DC-SIGN is required for dendritic cell infection and target cell trans-infection. Immunity 2002 17 : 6536 64.
8. Kwon DS, Gregorio G, Bitton N, Hendrickson WA, Littman DR. DC-SIGN-mediated internalization of HIV is required for trans-enhancement of T cell infection. Immunity 2002 16 : 135 44.
9. Geijtenbeek TB, van Vliet SJ, Koppel EA, Sanchez-Hernandez M, Vandenbroucke-Grauls CM, Appelmelk B, van Kooyk Y. Mycobacteria target DC-SIGN to suppress dendritic cell function. J Exp Med 2003 197 : 7 17.
10. Bergman MP, Engering A, Smits HH et al. Helicobacter pylori modulates the T helper cell 1/T helper cell 2 balance through phase-variable interaction between lipopolysaccharide and DC-SIGN. J Exp Med 2004 200 : 979 90.
11. Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med 2004 10 : 475 80.
12. Appelmelk BJDI, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003 170 : 1635 9.
13. Frison N, Taylor ME, Soilleux E, Bousser MT, Mayer R, Monsigny M, Drickamer K, Roche AC. Oligolysine-based oligosaccharide clusters. Selective recognition and endocytosis by the mannose receptor and dendritic cell-specific intercellular adhesion molecule 3 (ICAM-3) -grabbing nonintegrin. J Biol Chem 2003 278 : 23922 9.
14. van DI, van Vliet SJ, Nyame AK, Cummings RD, Bank CM, Appelmelk B, Geijtenbeek TB, van Kooyk Y. The dendritic cell-specific C-type lectin DC-SIGN is a receptor for Schistosoma mansoni egg antigens and recognizes the glycan antigen Lewis x. Glycobiology 2003 13 : 471 8.
15. Okano M, Satoskar AR, Nishizaki K, Harn DA Jr. Lacto-N-fucopentaose III found on Schistosoma mansoni egg antigens functions as adjuvant for proteins by inducing Th2-type response. J Immunol 2001 167 : 442 50.
16. Thomas PG, Harn DA Jr. Immune biasing by helminth glycans. Cell Microbiol 2004 6 : 13 22.
17. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci USA 1994 91 : 18 22.
18. van Gisbergen KP, Sanchez-Hernandez M, Geijtenbeek TB, van Kooyk Y. Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. J Exp Med 2005 201 : 1281 92.
19. Jankovic D, Kullberg MC, Noben-Trauth N, Caspar P, Paul WE, Sher A. Single cell analysis reveals that IL-4 receptor/Stat6 signaling is not required for the in vivo or in vitro development of CD4+ lymphocytes with a Th2 cytokine profile. J Immunol 2000 164 : 3047 55.
20. Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL. Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2. J Exp Med 1995 182 : 1435 45.
21. Tacken PJ, de Vries IJ, Gijzen K et al. Effective induction of naive and recall T-cell responses by targeting antigen to human dendritic cells via a humanized anti-DC-SIGN antibody. Blood 2005 106 : 1278 85.
22. Mahnke K, Guo M, Lee S, Sepulveda H, Swain SL, Nussenzweig M, Steinman RM. The dendritic cell receptor for endocytosis, DEC-205, can recycle and enhance antigen presentation via major histocompatibility complex class II-positive lysosomal compartments. J Cell Biol 2000 151 : 673 84.
23. Mahnke K, Qian Y, Fondel S, Brueck J, Becker C, Enk AH. Targeting of antigens to activated dendritic cells in vivo cures metastatic melanoma in mice. Cancer Res 2005 65 : 7007 12.
24. Maurer M, Seidel-Guyenot W, Metz M, Knop J, Steinbrink K. Critical role of IL-10 in the induction of low zone tolerance to contact allergens. J Clin Invest 2003 112 : 432 9.
25. Muller G, Muller A, Tuting T, Steinbrink K, Saloga J, Szalma C, Knop J, Enk AH. Interleukin-10-treated dendritic cells modulate immune responses of naive and sensitized T cells in vivo. J Invest Dermatol 2002 119 : 836 41.
26. Nolan KF, Strong V, Soler D et al. IL-10-conditioned dendritic cells, decommissioned for recruitment of adaptive immunity, elicit innate inflammatory gene products in response to danger signals. J Immunol 2004 172 : 2201 9.
27. Steinbrink K, Graulich E, Kubsch S, Knop J, Enk AH. CD4(+) and CD8(+) anergic T cells induced by interleukin-10-treated human dendritic cells display antigen-specific suppressor activity. Blood 2002 99 : 2468 76.
28. Grutz G. New insights into the molecular mechanism of interleukin-10-mediated immunosuppression. J Leukoc Biol 2005 77 : 3 15.
29. Roers A, Siewe L, Strittmatter E et al. T cell-specific inactivation of the interleukin 10 gene in mice results in enhanced T cell responses but normal innate responses to lipopolysaccharide or skin irritation. J Exp Med 2004 200 : 1289 97.
30. Akira S, Takeda K, Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat Immunol 2001 2 : 675 80.
31. Park CG, Takahara K, Umemoto E et al. Five mouse homologues of the human dendritic cell C-type lectin, DC-SIGN. Int Immunol 2001 13 : 1283 90.
32. Geijtenbeek TB, Groot PC, Nolte MA et al. Marginal zone macrophages express a murine homologue of DC-SIGN that captures blood-borne antigens in vivo. Blood 2002 100 : 2908 16.
33. Nagaoka K, Takahara K, Tanaka K et al. Association of SIGNR1 with TLR4-MD-2 enhances signal transduction by recognition of LPS in gram-negative bacteria. Int Immunol 2005 17 : 827 36.
34. Lanoue A, Clatworthy MR, Smith P et al. SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med 2004 200 : 1383 93.
35. Gourier C, Pincet F, Perez E, Zhang Y, Mallet JM, Sinay P. Specific and non specific interactions involving Le (X) determinant quantified by lipid vesicle micromanipulation. Glycoconj J 2004 21 : 165 74.